Immunity, inflammation and cancer

Concepció Soler Prat

PRINCIPAL INVESTIGATORS
  • Sonia-Vanina Forcales Fernández
  • Joan Manils Pacheco
  • Sara Preciado Gallego
  • Juan José Rojas Expósito
CLINICAL RESEARCHERS
  • Jaime Notario Rosa
POSTDOCTORAL RESEARCHERS
  • Ignacio Sallent Cucurella
PREDOCTORAL RESEARCHERS
  • Maria Barcia Ramos
  • Carmen Bueno Merino
  • Margalida Cabrer Frau
  • Miquel Conesa Torrandell
  • Daniel López Ramajo
  • Maria Martin Agramunt
  • Dayana Pino Jimenez
Cancer
Oncobell

Scientific production

6

PAPERS

Average IF: 5,82

3

LED PAPER

Average IF: 6,43

2 PUBLICATION IN FIRST DECILE

5 PUBLICATIONS IN FIRST QUARTILE

6 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Casas,E;Mitjavila Ventura,A;Sierra,P;Moreta Moraleda,C;Cebria,J;Panzeri,I;Pospisilik,JA et al, Genetic polymorphisms lead to major, locus-specific, variation in piRNA production in mouse., EMBO J, 2025;44(14):1-16, doi:10.1038/s44318-025-00475-4
  • Queralt,C;Moreta Moraleda,C;Costa,M;Grau Leal,F;Diesch,J;Vendrell Ayats,C;Musulén,E et al, Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer., Clin. Transl. Med., 2025;15(12); doi:10.1002/ctm2.70543
  • Aidarova,A;Carels,M;Haegman,M;Driege,Y;Timmermans,S;Van Damme,E;Aguilera Lizarraga,J et al, CARD14 signaling in intestinal epithelial cells induces intestinal inflammation and intestinal transit delay, EMBO Mol Med, 2025;17(12):3300-3328, doi:10.1038/s44321-025-00321-4
  • Llimós Aubach,J;Andres Bilbe,A;Pujol Coma,A;Castellanos,A;Pallás,I;Bahamonde,MI;de Anta,JM et al, TRESK background potassium channel regulates MrgprA3 + pruriceptor excitability, acute and chronic itch., Pain, 2025;166(8):1796-1810, doi:10.1097/j.pain.0000000000003540
  • Notario,J;Magdaleno Tapial,J;Rivera,R;Riera Monroig,J;Pujol,C;Novella,C;Cuervas Mons,M et al, Demographic and Clinical Characteristics, Patterns of Treatment, Quality of Life, and Resource Consumption Associated with the Management of Patients with Moderate to Severe Psoriasis in Clinical Practice in Spain: The SUMMER Project., Dermatol Ther (Heidelb), 2025;16(1):473-486, doi:10.1007/s13555-025-01591-z
  • Kane,LE;Flood,B;Manils,J;Mcskeane,DE;Smith,AP;Tosetto,M;Alalawi,F et al, Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer, Gastro Hep Adv., 2025;4(2):100552-100552, doi:10.1016/j.gastha.2024.09.007

Research highlights

PROJECTS

2 Granted competitive projects
3 Ongoing competitive projects

PUBLISHED WORKS

1 Thesis

INNOVATION

2 Patents

NETWORKS

RICORS -TERAV

Selected projects

  • CI25-30479. TREX2 inhibitors: a breakthrough keratinocyte-based therapy for Psoriasis and beyond. FUNDACIÓ “LA CAIXA”. Budget: 499.999,50€. 2025-2027. PI: SARA PRECIADO GALLEGO.
  • LABAE223473ROJA. Towards a viral immunotherapy able to generate robust antitumor immune responses. Asociación Española Contra el Cáncer (AECC). Budget: 215.071,91€. 2022-2026. PI: JUAN JOSÉ ROJAS EXPÓSITO.
  • 2025 PROD 00038. Improved viral immunotherapies for the treatment of solid tumors. AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. Budget: 149.937,35€. 2025-2027. PI: JUAN JOSÉ ROJAS EXPÓSITO.